VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q88993397 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000219.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q88993397‏
024 ‎‡a 0000-0002-0909-2963‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q88993397‏
100 0 ‎‡a D-Y Wang‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a D-Y Wang‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A compendium answering 150 questions on COVID-19 and SARS-CoV-2‏
670 ‎‡a Author's Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties‏
670 ‎‡a Author's Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma‏
670 ‎‡a Author's Do NERDy eosinophils accelerate nasal polyp growth?‏
670 ‎‡a Author's Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia‏
670 ‎‡a Author's Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care‏
670 ‎‡a Author's HIF-1α induces NLRP3 expression by M1 macrophages in non-eosinophilic chronic rhinosinusitis with nasal polyps‏
670 ‎‡a Author's Infiltration pattern of gammadelta T cells and its association with local inflammatory response in the nasal mucosa of patients with allergic rhinitis‏
670 ‎‡a Author's Novel findings in immunopathophysiology of chronic rhinosinusitis and their role in a model of precision medicine‏
670 ‎‡a Author's Precision medicine in united airways disease: A "treatable traits" approach‏
670 ‎‡a Author's Prevalence of pollen-induced allergic rhinitis with high pollen exposure in grasslands of northern China.‏
670 ‎‡a Author's Recent developments and highlights in rhinitis and allergen immunotherapy‏
670 ‎‡a Author's Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis‏
670 ‎‡a Author's Role of IL-13Rα2 in modulating IL-13 induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa‏
670 ‎‡a Author's Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type-2 inflammation‏
670 ‎‡a Author's Role of microRNAs in inflammatory upper airway diseases‏
670 ‎‡a Author's Role of Yes-associated protein in Interleukin-13 induced nasal remodeling of chronic rhinosinusitis with nasal polyps‏
670 ‎‡a Author's The hippo pathway effector YAP promotes epithelial proliferation and remodeling in chronic rhinosinusitis with nasal polyps‏
670 ‎‡a Author's The microdissected gene expression landscape of nasopharyngeal cancer reveals vulnerabilities in FGF and noncanonical NF-κB signaling‏
670 ‎‡a Author's Update about Oralair® as a treatment for grass pollen allergic rhinitis‏
670 ‎‡a Author's Using Patient Profiles To Guide The Choice Of Antihistamines In The Primary Care Setting In Malaysia: Expert Consensus And Recommendations‏
670 ‎‡a Author's Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives‏
670 ‎‡a Author's Whole-transcriptome sequencing reveals heightened inflammation and defective host defence responses in chronic rhinosinusitis with nasal polyps‏
909 ‎‡a (orcid) 0000000209092963‏ ‎‡9 1‏
912 ‎‡a rhinitisassociatedwithasthmaisdistinctfromrhinitisalonethescpariamedallscphypothesis‏ ‎‡A Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis‏ ‎‡9 1‏
919 ‎‡a hippopathwayeffectoryappromotesepithelialproliferationandremodelinginchronicrhinosinusitiswithnasalpolyps‏ ‎‡A The hippo pathway effector YAP promotes epithelial proliferation and remodeling in chronic rhinosinusitis with nasal polyps‏ ‎‡9 1‏
919 ‎‡a microdissectedgeneexpressionlandscapeofnasopharyngealcancerrevealsvulnerabilitiesinfgfandnoncanonicalnfκbsignaling‏ ‎‡A The microdissected gene expression landscape of nasopharyngeal cancer reveals vulnerabilities in FGF and noncanonical NF-κB signaling‏ ‎‡9 1‏
919 ‎‡a usingpatientprofilestoguidethechoiceofantihistaminesintheprimarycaresettinginmalaysiaexpertconsensusandrecommendations‏ ‎‡A Using Patient Profiles To Guide The Choice Of Antihistamines In The Primary Care Setting In Malaysia: Expert Consensus And Recommendations‏ ‎‡9 1‏
919 ‎‡a vaccinesandallergicreactionsthepastthecurrentcovid19pandemicandfutureperspectives‏ ‎‡A Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives‏ ‎‡9 1‏
919 ‎‡a wholetranscriptomesequencingrevealsheightenedinflammationanddefectivehostdefenceresponsesinchronicrhinosinusitiswithnasalpolyps‏ ‎‡A Whole-transcriptome sequencing reveals heightened inflammation and defective host defence responses in chronic rhinosinusitis with nasal polyps‏ ‎‡9 1‏
919 ‎‡a donerdyeosinophilsacceleratenasalpolypgrowth‏ ‎‡A Do NERDy eosinophils accelerate nasal polyp growth?‏ ‎‡9 1‏
919 ‎‡a biomarkersfordiagnosisandpredictionoftherapyresponsesinallergicdiseasesandasthma‏ ‎‡A Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma‏ ‎‡9 1‏
919 ‎‡a antihistaminesforallergicrhinitistreatmentfromtheviewpointofnonsedativeproperties‏ ‎‡A Antihistamines for Allergic Rhinitis Treatment from the Viewpoint of Nonsedative Properties‏ ‎‡9 1‏
919 ‎‡a compendiumanswering150questionsoncovid19andsarscov2‏ ‎‡A A compendium answering 150 questions on COVID-19 and SARS-CoV-2‏ ‎‡9 1‏
919 ‎‡a updateaboutoralairasatreatmentforgrasspollenallergicrhinitis‏ ‎‡A Update about Oralair® as a treatment for grass pollen allergic rhinitis‏ ‎‡9 1‏
919 ‎‡a enteroviral3cproteaseactivatesthehumannlrp1inflammasomeinairwayepithelia‏ ‎‡A Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia‏ ‎‡9 1‏
919 ‎‡a futureresearchtrendsinunderstandingthemechanismsunderlyingallergicdiseasesforimprovedpatientcare‏ ‎‡A Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care‏ ‎‡9 1‏
919 ‎‡a hif1αinducesnlrp3expressionbym1macrophagesinnoneosinophilicchronicrhinosinusitiswithnasalpolyps‏ ‎‡A HIF-1α induces NLRP3 expression by M1 macrophages in non-eosinophilic chronic rhinosinusitis with nasal polyps‏ ‎‡9 1‏
919 ‎‡a infiltrationpatternofgammadeltatcellsanditsassociationwithlocalinflammatoryresponseinthenasalmucosaofpatientswithallergicrhinitis‏ ‎‡A Infiltration pattern of gammadelta T cells and its association with local inflammatory response in the nasal mucosa of patients with allergic rhinitis‏ ‎‡9 1‏
919 ‎‡a novelfindingsinimmunopathophysiologyofchronicrhinosinusitisandtheirroleinamodelofprecisionmedicine‏ ‎‡A Novel findings in immunopathophysiology of chronic rhinosinusitis and their role in a model of precision medicine‏ ‎‡9 1‏
919 ‎‡a precisionmedicineinunitedairwaysdiseaseatreatabletraitsapproach‏ ‎‡A Precision medicine in united airways disease: A "treatable traits" approach‏ ‎‡9 1‏
919 ‎‡a prevalenceofpolleninducedallergicrhinitiswithhighpollenexposureingrasslandsofnorthernchina‏ ‎‡A Prevalence of pollen-induced allergic rhinitis with high pollen exposure in grasslands of northern China.‏ ‎‡9 1‏
919 ‎‡a recentdevelopmentsandhighlightsinrhinitisandallergenimmunotherapy‏ ‎‡A Recent developments and highlights in rhinitis and allergen immunotherapy‏ ‎‡9 1‏
919 ‎‡a roleofil13rα2inmodulatingil13inducedmuc5acandciliarychangesinhealthyandcrswnpmucosa‏ ‎‡A Role of IL-13Rα2 in modulating IL-13 induced MUC5AC and ciliary changes in healthy and CRSwNP mucosa‏ ‎‡9 1‏
919 ‎‡a roleofil25il33andtslpintriggeringunitedairwaydiseasestowardtype2inflammation‏ ‎‡A Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type-2 inflammation‏ ‎‡9 1‏
919 ‎‡a roleofmicrornasininflammatoryupperairwaydiseases‏ ‎‡A Role of microRNAs in inflammatory upper airway diseases‏ ‎‡9 1‏
919 ‎‡a roleofyesassociatedproteinininterleukin13inducednasalremodelingofchronicrhinosinusitiswithnasalpolyps‏ ‎‡A Role of Yes-associated protein in Interleukin-13 induced nasal remodeling of chronic rhinosinusitis with nasal polyps‏ ‎‡9 1‏
996 ‎‡2 NKC|xx0301222
996 ‎‡2 DNB|1276447876
996 ‎‡2 DNB|1060770350
996 ‎‡2 LC|n 2016047450
996 ‎‡2 J9U|987007362337505171
996 ‎‡2 LC|n 86830770
996 ‎‡2 CYT|AC000659453
996 ‎‡2 ISNI|0000000037455472
996 ‎‡2 PLWABN|9812443686405606
996 ‎‡2 DNB|116914389X
996 ‎‡2 LC|n 84157110
996 ‎‡2 LC|nr 95000156
996 ‎‡2 ISNI|0000000403178912
996 ‎‡2 LC|nr 90028540
996 ‎‡2 DNB|1049959272
996 ‎‡2 LC|n 2023066569
996 ‎‡2 LC|n 2017012756
996 ‎‡2 LC|n 2019000543
996 ‎‡2 LC|no2009068811
996 ‎‡2 ISNI|0000000444587536
996 ‎‡2 DNB|1300350997
996 ‎‡2 LC|no2016019577
996 ‎‡2 CAOONL|ncf11868614
996 ‎‡2 SZ|1236964306
996 ‎‡2 CYT|AC000659697
996 ‎‡2 LC|n 2012057797
996 ‎‡2 DNB|132434718X
996 ‎‡2 LC|no2009054436
996 ‎‡2 NTA|177050691
996 ‎‡2 DNB|1094906484
996 ‎‡2 CYT|AC000163577
996 ‎‡2 LC|n 79113592
996 ‎‡2 LC|no2010122788
996 ‎‡2 NUKAT|n 2007134023
996 ‎‡2 NKC|xx0124043
996 ‎‡2 LC|n 2019043360
996 ‎‡2 DNB|1053580126
996 ‎‡2 J9U|987007323382405171
996 ‎‡2 CAOONL|ncf10288780
996 ‎‡2 ISNI|0000000408764283
996 ‎‡2 ISNI|0000000050026015
996 ‎‡2 LC|n 2009078916
996 ‎‡2 ISNI|0000000082580010
996 ‎‡2 J9U|987007324420605171
996 ‎‡2 LC|nr2002012180
996 ‎‡2 LC|no2015081643
996 ‎‡2 DNB|1022836714
996 ‎‡2 ISNI|000000006337756X
996 ‎‡2 LC|no2021133541
996 ‎‡2 ISNI|0000000498858987
996 ‎‡2 LC|no2016041492
996 ‎‡2 CYT|AC000127170
996 ‎‡2 ISNI|0000000049474806
996 ‎‡2 LC|no2006109893
996 ‎‡2 BNF|17082665
996 ‎‡2 LC|no2023130640
996 ‎‡2 ISNI|0000000082630954
996 ‎‡2 SUDOC|12058591X
996 ‎‡2 ISNI|0000000486517544
996 ‎‡2 CYT|AC000143593
996 ‎‡2 DNB|139901582
996 ‎‡2 DNB|1254182160
996 ‎‡2 LC|n 2019056218
996 ‎‡2 DNB|1307976662
996 ‎‡2 ISNI|0000000075321184
996 ‎‡2 DNB|128531137X
996 ‎‡2 ISNI|0000000041259095
996 ‎‡2 ISNI|0000000049634830
996 ‎‡2 CYT|AC000642080
996 ‎‡2 LC|n 78048253
996 ‎‡2 ISNI|0000000064351492
996 ‎‡2 ISNI|0000000023267788
996 ‎‡2 LC|n 2024027384
996 ‎‡2 SUDOC|162291507
996 ‎‡2 ISNI|0000000027828837
996 ‎‡2 CYT|AC000161592
996 ‎‡2 LC|n 84132735
996 ‎‡2 ISNI|0000000444602433
996 ‎‡2 LC|n 83024044
996 ‎‡2 ISNI|0000000064080952
996 ‎‡2 LC|n 2008037451
996 ‎‡2 ISNI|0000000029190144
996 ‎‡2 LC|no 97057734
996 ‎‡2 ISNI|0000000387924785
996 ‎‡2 LC|n 2017064030
996 ‎‡2 LC|n 86007830
996 ‎‡2 DNB|1194885063
996 ‎‡2 CYT|AC000643970
996 ‎‡2 NUKAT|n 2015125946
996 ‎‡2 LC|no2009155602
996 ‎‡2 DNB|1019705787
996 ‎‡2 LC|n 2007033629
996 ‎‡2 LC|n 80045685
996 ‎‡2 ISNI|0000000468128238
996 ‎‡2 DNB|1211279693
996 ‎‡2 CYT|AC000264596
996 ‎‡2 DNB|1177172585
996 ‎‡2 LC|nr2001023225
996 ‎‡2 LC|n 80068808
996 ‎‡2 ISNI|0000000083195587
996 ‎‡2 ISNI|0000000088277346
996 ‎‡2 ISNI|0000000452089051
996 ‎‡2 ISNI|000000011251105X
996 ‎‡2 BNF|17128031
996 ‎‡2 ISNI|0000000063458060
996 ‎‡2 PLWABN|9812692453005606
996 ‎‡2 DBC|87097947422574
996 ‎‡2 BNF|17721847
996 ‎‡2 ISNI|0000000109559757
996 ‎‡2 ISNI|0000000063388146
996 ‎‡2 ISNI|000000036037797X
996 ‎‡2 LC|n 2007032760
996 ‎‡2 NTA|140557016
996 ‎‡2 SUDOC|035625198
996 ‎‡2 NII|DA02510369
996 ‎‡2 LC|n 85333952
996 ‎‡2 LC|n 85114118
996 ‎‡2 NUKAT|n 2009166066
996 ‎‡2 ISNI|0000000063715127
996 ‎‡2 LC|n 80027761
996 ‎‡2 CYT|AC000400833
996 ‎‡2 LC|n 2010184950
996 ‎‡2 CYT|AC000375903
996 ‎‡2 LC|nr 96020811
996 ‎‡2 ISNI|0000000063868473
996 ‎‡2 LC|n 85236556
996 ‎‡2 CAOONL|ncf10506730
996 ‎‡2 ISNI|0000000063478483
996 ‎‡2 LC|nr 97016119
996 ‎‡2 NUKAT|n 2017173691
996 ‎‡2 DNB|1175011096
996 ‎‡2 ISNI|0000000043548659
996 ‎‡2 LC|no2013124484
996 ‎‡2 ISNI|0000000063382457
996 ‎‡2 CYT|AC000127642
996 ‎‡2 CYT|AC000210016
996 ‎‡2 SUDOC|116518022
996 ‎‡2 SUDOC|171627687
996 ‎‡2 LC|n 89125506
996 ‎‡2 LC|n 2016035519
996 ‎‡2 BNF|17119812
996 ‎‡2 CYT|AC000650292
996 ‎‡2 ISNI|0000000040629525
996 ‎‡2 ISNI|0000000391011946
996 ‎‡2 ISNI|0000000063808294
996 ‎‡2 BIBSYS|90270020
996 ‎‡2 CYT|AC000640718
996 ‎‡2 CAOONL|ncf13724084
996 ‎‡2 ISNI|0000000053539238
996 ‎‡2 DNB|1206811447
996 ‎‡2 DNB|1141796457
996 ‎‡2 NII|DA18230929
996 ‎‡2 BNF|12563436
996 ‎‡2 LC|no2021092437
996 ‎‡2 PTBNP|1881247
996 ‎‡2 NUKAT|n 00043767
996 ‎‡2 NTA|14619909X
996 ‎‡2 LC|nb2008001001
996 ‎‡2 CYT|AC000065375
996 ‎‡2 NII|DA10439270
996 ‎‡2 LC|no2011100743
996 ‎‡2 BNF|18131907
996 ‎‡2 LC|no2020102836
996 ‎‡2 PLWABN|9810578850605606
996 ‎‡2 DNB|127142851
996 ‎‡2 CYT|AC000154066
996 ‎‡2 PLWABN|9813130640605606
996 ‎‡2 ISNI|0000000081336630
996 ‎‡2 ISNI|0000000116701811
996 ‎‡2 NKC|jo2017969683
996 ‎‡2 LC|n 2005030305
996 ‎‡2 CYT|AC000641539
996 ‎‡2 LC|no2012113896
996 ‎‡2 DNB|1341253341
996 ‎‡2 DNB|133268212X
996 ‎‡2 LC|no2020084562
996 ‎‡2 CYT|AC000647386
996 ‎‡2 DNB|1268542172
996 ‎‡2 LC|no2013024479
996 ‎‡2 CYT|AC000259539
996 ‎‡2 DNB|1210082403
996 ‎‡2 LC|nr 92025778
996 ‎‡2 J9U|987007348229805171
996 ‎‡2 LC|n 2005208899
996 ‎‡2 ISNI|000000012136627X
996 ‎‡2 DNB|1232652024
996 ‎‡2 LC|n 99010980
996 ‎‡2 CYT|AC000587271
996 ‎‡2 LC|n 2020007695
996 ‎‡2 DNB|142673153
996 ‎‡2 DNB|1331345650
996 ‎‡2 CAOONL|ncf10143662
996 ‎‡2 SUDOC|159739705
996 ‎‡2 CYT|AC000641994
996 ‎‡2 LC|no2010020696
996 ‎‡2 LC|n 2017022691
996 ‎‡2 LC|n 2008037023
996 ‎‡2 LC|n 2002060364
996 ‎‡2 LC|n 2013009383
996 ‎‡2 DNB|1153934957
996 ‎‡2 LC|no2005120071
996 ‎‡2 NTA|22746107X
996 ‎‡2 LC|no2009073686
996 ‎‡2 LC|n 87873038
996 ‎‡2 LC|n 2014067287
996 ‎‡2 LC|no2006136731
996 ‎‡2 BIBSYS|13070357
996 ‎‡2 CAOONL|ncf11217068
996 ‎‡2 LC|n 2020049582
996 ‎‡2 LC|no2013060026
996 ‎‡2 CYT|AC000160552
996 ‎‡2 ISNI|000000044242395X
996 ‎‡2 LC|n 85306108
996 ‎‡2 ISNI|0000000064225111
996 ‎‡2 CYT|AC000161034
996 ‎‡2 DNB|1029449597
996 ‎‡2 BNF|18103640
996 ‎‡2 DNB|1192691644
996 ‎‡2 ISNI|0000000063967076
996 ‎‡2 CYT|AC000160520
996 ‎‡2 ISNI|0000000390709613
996 ‎‡2 LC|nr 97041279
996 ‎‡2 NTA|422871494
996 ‎‡2 SUDOC|231703864
996 ‎‡2 ISNI|0000000077698663
996 ‎‡2 DNB|1256850365
996 ‎‡2 LC|n 2005070277
996 ‎‡2 NII|DA11676715
996 ‎‡2 J9U|987007412649105171
996 ‎‡2 ISNI|0000000063674038
996 ‎‡2 LC|no 00087480
996 ‎‡2 NLR|RU NLR AUTH 770151345
996 ‎‡2 LC|nr 95017219
996 ‎‡2 LC|no2009032114
996 ‎‡2 LC|n 2013064683
996 ‎‡2 LC|nb2009029128
996 ‎‡2 DNB|1230085025
996 ‎‡2 LC|n 2015014550
996 ‎‡2 NTA|14208848X
996 ‎‡2 DNB|1061987582
996 ‎‡2 RERO|A020263869
996 ‎‡2 DNB|1206812648
996 ‎‡2 LC|n 87928964
996 ‎‡2 CYT|AC000160452
996 ‎‡2 DNB|129406708
996 ‎‡2 NTA|148367682
996 ‎‡2 DNB|133989925
996 ‎‡2 LC|n 2008083648
996 ‎‡2 LC|n 78047007
996 ‎‡2 DNB|136409342
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏